CAMBRIDGE, Mass.--(BUSINESS WIRE)--AVEO Pharmaceuticals, Inc. (NASDAQ: AVEO), a biopharmaceutical company focused on discovering, developing and commercializing cancer therapeutics, today announced that Tuan Ha-Ngoc, president and chief executive officer of AVEO, will close the NASDAQ stock market on Tuesday, June 22, 2010. Members of the AVEO executive leadership team and AVEO co-founders will join Mr. Ha-Ngoc and Anthony Evnin, Ph.D., chairman of the Board of Directors, at the ceremony at the NASDAQ MarketSite in Times Square in New York City.
